LEADER 01912nam  2200469   450 
001 9910460726003321
005 20200520144314.0
010   $a1-68108-056-7
035   $a(CKB)3710000000531592
035   $a(EBL)4412584
035   $a(MiAaPQ)EBC4412584
035   $a(Au-PeEL)EBL4412584
035   $a(CaPaEBR)ebr11204970
035   $a(OCoLC)951064879
035   $a(EXLCZ)993710000000531592
100   $a20160614h20152015  uy|            0
101 0 $aeng
135   $aur|n|---|||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aAdvances in HIV treatment $eHIV enzyme inhibitors and antiretroviral therapy /$fedited by Gene D. Morse, New York State Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo (UB), Buffalo, New York, USA & Sarah Nanzigu, Department of Pharmacology and Therapeutics, Makerere University College of Health Science, Kampala, Uganda
210  1$aSharjah :$cBentham Science Publishers, Limited,$d[2015]
210  4$dİ2015
215   $a1 online resource (168 p.)
225 0 $aFrontiers in HIV research ;$vvolume 1
300   $aIncludes index.
311   $a1-68108-057-5 
327   $a01 COver; 02 Title; 03 F End User Licence Terms - Non-Institutional Personal Use; 04 Contents; 05 Foreword; 06 Preface; 07 LOC; 07b Acknowledgements; 08 Chapter 01; 08 Chapter 02; 08 Chapter 03; 08 Chapter 04; 08 Chapter 05; 08 Chapter 06; 08 Chapter 07; 08 Chapter 08; 09 Index; 10 Back COver
410  0$aFrontiers in HIV research ;$vv. 1.
606   $aHIV infections$xPrevention
608   $aElectronic books.
615  0$aHIV infections$xPrevention.
702   $aMorse$b Gene D.
702   $aNanzigu$b Sarah
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910460726003321
996   $aAdvances in HIV treatment$91994667
997   $aUNINA